Consensus Statement on the Use of Cepheid Xpert MTB/RIF Assay in Making Decisions to Discontinue Airborne Infection Isolation in Healthcare Settings

The purpose of this document is to provide guidance for clinicians, nurses, and hospital infection preventionists on the use of the Xpert MTB/RIF assay when making decisions to discontinue airborne infection isolation for persons with suspected, infectious pulmonary TB.

Author:

Association of Public Health Laboratories, National Tuberculosis Controllers Association, Association of Public Health Laboratories, APHL, NTCA

Format:

Guideline

Publication Date:

2016

ID:

34015

Audiences

Infection Control and Occupational Health Workers

Focus Area

TB

Topic

Infection Control
Diagnosis- Laboratory Procedures

Related Materials

Materials

Doxy PEP Doxycycline Post-Exposure Prophylaxis (Doxy PEP) Protocol

Materials

Vaginitis and Risk of Sexually Transmitted Infections: Results of a Multi-Center U.S. Clinical Study Using STI Nucleic Acid Amplification Testing

Materials

Improving Maternal Health Lessons Learned from States Addressing Congenital Syphilis

Materials

Biosafety Recommendations for Individuals Handling Carcasses from Animals Known or Suspected to Have Tuberculosis

Back to Results

Consensus Statement on the Use of Cepheid Xpert MTB/RIF Assay in Making Decisions to Discontinue Airborne Infection Isolation in Healthcare Settings

Related Materials

CDC NPIN Resources